1002309-36-5 Usage
Description
(6-phenylimidazo[1,2-b]pyridazin-3-yl)methanol, a chemical compound with the molecular formula C14H11N3O, is a white to beige solid at room temperature. It is characterized by its unique chemical structure and potential medicinal properties, making it a valuable compound for further research and development in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
(6-phenylimidazo[1,2-b]pyridazin-3-yl)methanol is used as a compound in the development of drugs for various purposes, including anti-cancer, anti-inflammatory, and anti-bacterial treatments.
Used in Anticancer Applications:
In the field of oncology, (6-phenylimidazo[1,2-b]pyridazin-3-yl)methanol is used as a potential anti-cancer agent. Research has shown that it can inhibit the growth of cancer cells, making it a promising candidate for further study and development in cancer treatment.
Used in Anti-Inflammatory Applications:
(6-phenylimidazo[1,2-b]pyridazin-3-yl)methanol is also used as an anti-inflammatory agent. Its potential to alleviate inflammation and reduce swelling makes it a valuable compound for the development of medications targeting inflammatory conditions.
Used in Anti-Bacterial Applications:
Furthermore, (6-phenylimidazo[1,2-b]pyridazin-3-yl)methanol has shown promise in the treatment of bacterial infections. Its ability to combat bacterial pathogens positions it as a potential candidate for the development of new antibiotics to address the growing issue of antibiotic resistance.
Check Digit Verification of cas no
The CAS Registry Mumber 1002309-36-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,2,3,0 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1002309-36:
(9*1)+(8*0)+(7*0)+(6*2)+(5*3)+(4*0)+(3*9)+(2*3)+(1*6)=75
75 % 10 = 5
So 1002309-36-5 is a valid CAS Registry Number.
1002309-36-5Relevant articles and documents
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
-
Page/Page column 107, (2010/11/29)
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
